Daniela Hurtado, an endocrinologist at the Mayo Clinic (as quoted in Kritz, 2025)
Important Safety & Usage Advisory
While rare, several post-marketing reports and some large database studies suggest a possible increased risk of NAION associated with certain GLP-1 RAs, including semaglutide
May 27, 2016
Tesamorelin vs CJC-1295 vs Sermorelin: GHRH Analog Comparison for Research Durham Peptides May 16 7 min read Updated: 1 day ago Tesamorelin vs CJC-1295 vs sermorelin GHRH analog comparison Durham Peptides Canada Three of the most-discussed GHRH analogs in research peptide contexts tesamorelin, CJC-1295, and sermorelin share the same fundamental mechanism (GHRH receptor agonism) but differ substantially in structural features, half-life, and research properties
It will be quite negative for our patients because data shows people typically regain weight after stopping the drugs, said Diana Thiara, medical director of the University of California-San Francisco Weight Management Program
.webp)
